Antagonists of interleukin-15

Details Antagonists of interleukin-15 Antagonists of interleukin-15

2007-08-21

2007-08-21

Mertz, Prema (Department: 1646)

Drug, bio-affecting and body treating compositions

Lymphokine

Interleukin

C514S002600, C514S008100, C514S012200, C514S825000

Reexamination Certificate

active

10245243

ABSTRACT:
Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.

REFERENCES:
patent: 5011684 (1991-04-01), Strom
patent: 5116964 (1992-05-01), Capon et al.
patent: 5262522 (1993-11-01), Gearing
patent: 5552303 (1996-09-01), Grabstein et al.
patent: 5574138 (1996-11-01), Grabstein et al.
patent: 5707616 (1998-01-01), Grabstein et al.
patent: 5747024 (1998-05-01), Grabstein et al.
patent: 5892001 (1999-04-01), Grabstein et al.
patent: 6451308 (2002-09-01), Strom et al.
patent: WO88/07089 (1988-09-01), None
patent: WO95/27722 (1995-10-01), None
patent: WO96/04306 (1996-02-01), None
patent: WO96/26274 (1996-08-01), None
Mikayama et al. Proc. Natl. Acad. Sci. USA vol. 90, pp. 10056-10060.
Voet et al. Biochemistry John Wiley & Sons, Inc., pp. 126-128 and 228-234.
The Merck Manual of Diagnosis and Therapy. Beers and Berkow. 17thedition, 1999. pp. 416-430.
Akatsuka et al., “Synovial Mononuclear Cells Consist with T Cells Which Produce High Level . . . ” Microbiol. Immunol., 41:4, 367-370 (1997).
Anderson et al., Functional Characterization of the Human Interleukin-15 Receptor . . . J. Bio. Chem. 270:29862-29869 (1995).
Armitage et al., IL-15 Has Stimulatory Activity for the Induction of B Cell Proliferation and Differentiation, J. Immunology, 154:483-490 (1995).
Bamford et al., The interleukin (IL) 2 receptor β chain is shared by IL-2 and cytokine, provisionally designated IL-T . . . Proc. Nat. Acad. Sciences 91:4940-4944 (1994).
Blanar et al., “Interaction Cloning: Identification of a Helix-Loop-Helix Zipper Protein That Interacts with c-Fos”, Science 256:1014-1018 (1992).
Brekke et al., Structure-Function Relationships of Human IgG, The Immunologist 2:125-130 (1994).
Burger et al., “Imbalance between intersitital collagenase and tissue inhibitor of metalloproteinase l . . . ”, Arthritis & Rheumatism 41:10 (1998).
Burton et al., A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line . . . Proc. Nat. Acad. Sciences 91:4935-4939 (1994).
Carson et al., Interleukin (IL) 15 Is a Novel Cytokine That Activates Human Natural Killer Cells via Components of the IL-2 Receptor, J. Exper. Medicine 180:1395-1403 (1994).
Chae et al., “Mutant IL-15 Protein Exerting Antagonistic Effects on IL-15 Triggered Cell Proliferation”, J. American Society of Nephrology 7:1654 (1996).
Chae et al., Distribution of IL-15 Receptor a-Chains on Human Peripheral Blood Mononuclear Cells and Effect of . . . American Association of Immunologists (1996).
Courtenay et al., “Immunisation against heterologous type II collagen induces arthritis in mice”, Nature 283:5748 (1980).
Cunningham et al., “High-Resoluction Epitope Mapping of HGH-Receptor . . . ” Science 244, 1081-1085 (1989).
Elliott et al., “Repeated therapy with monoclonal antibody to tumour necrosis factor . . . ” Lancet 344:8930 (1994).
Elliott et al., “Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor . . . ” Lancet 344:8930 (1994).
George et al., “Current methods in sequence comparison and analysis”, Macromolecular Sequencing and Synthesis Selected methods and Applications, p. 127-149 (1988).
Giri et al., “IL-15, A Novel T Cell Growth Factor That Shares Activities and Receptor Components with IL-2”, J. Leukocyte Biology, 57:763-766 (1995).
Giri et al., “Identification and cloning of a novel IL-15 binding protein that is structurally related to . . . ” EMBO Journal 14:3654-3663 (1995).
Giri et al., Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15, EMBO Journal 13:2822-2830 (1994).
Grabstein et al., Cloning of a T Cell Growth Factor That Interacts . . . Science 264:965-968 (1994).
Hatakeyama et al., A Restricted Cytoplasmic Region of IL-2 Receptor . . . Cell 59:837-845 (1989).
Kim et al., Targeting the ll-15 Receptor with an Antagonist IL-15 Mutant/Fcy2a Protein Blocks Delayed-type Hypersensitivity Journal of Immunology 160:5742-5748 (1998).
Isler et al., “Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69” Eur. Cytokine Netw., 4:1 15-23, (1993).
Knight et al., “Construction and initial characterization of a mouse-human chimeric anti-TNF antibody” Molecular Immunology 30:16, 1443-1453 (1993).
LeClair et al., The p50 subunit of NF-xB associates with the NF-IL6 transcription factor, Proc. Nat. Acad. Sciences 89:8145-8149 (1992).
Lin et al., The Role of Shared Receptor Motifs and Common Stat Proteins in the Generation of Cytokine. Immunity 2:331-339 (1995).
Maslinski et al., Interleukin-2 (IL-2) Induces Tyrosine Kinase-dependent Translocation of Active. J. Biological Chemistry 267:15281-15284 (1992).
Maslinski et al., Intoxication of high affinity IL-2 receptor positive thymocytes blocks early stages of T cell maturation, International Immunology 4:509-517 (1992).
Moreland et al., Treatment of Rheumatoid Arthritis with A Recombinant Human Tumor Necrosis Factor Receptor (p75)-Fc Fusion Protein NEJM 337:3, 141-147 (1997).
Miltenburg et al., “Immobilized Anti-CD3 Antibody Activates T Cell Clones to Induce the Production of Interstitial Collagenase, but Not Tissue Inhibitor . . . ” The Journal of Immunology 154:6 (1995).
Morrison et al., Structural Determinants of Human IgG Function, The Immunologist 2:119-124 (1994).
Nickerson et al., Prolonged Islet Allograft Acceptance in the Absence of Interleukin 4 Extression; Transplant Immunology, 4:81-85 (1996).
Pettit et al., Structure-Function Studies of Interleukin 15 using Site-specific Mutagenesis, Polyethylene Glycol . . . J. Biological Chemistry, 2312-2318 (1997).
Pettit et al., “Polyethylene Glycol Conjugation to Lysine Residues of Recombinant IL-15 Generates a Specific IL-15 Antagonist”, Pro. of the Int. Symp. on Cont. Release Bioactive Materials; 22:496/497 (1995).
Remillard et al., Interleukin-2 Receptor Regulates Activation of Phosphatidylinositol 3-Kinase, Journal of Biological Chemistry 266:14167-14170 (1991).
Rezzonico et al., “Direct Contact between T Lymphocytes and Human Dermal Fibroblasts of Synoviocytes”, Journal of Biological Chemistry 273:30, 18720-18728 (1998).
Stevens et al., Interleukin-15 signals T84 colonic epithelial cells . . . The American Physiological Society (1997).
Williams et al., “Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anit-CD4” Immunology 84:3, 439-439 (1995).
Wooley et al., “Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice” The Journal of Immunology 151:11, 6602-6607 (1993).
Vey et al., “IFN-γ and 1,25 (OH)2D3Induce on THP-1 Cells Distinct Patterns of Cell Surface Antigen Expression . . .”, The Journal of Immunology 149:6, 2040-2046 (1992).
Ameglio et al., J. Biol. Regul. Homest. Agents, 13(4):220-224, 1999.
Ajjan et al.,J. Clin. Endocrinol. Metab.82(2):666-669, 1997.
Aringer et al., Rheumatology (Oxford) 40(8):8760881, 2001.
Baan et al., Clin. Transplant. 12(3):212-218, 1998.
Baan et al.,Transplant Proc.31(7):2726-2728, 1999.
Baan et al.,Transplantation67(6):870-876, 1999.
Baan et al.,Clin. Transplant.12(3):212-218, 1998.
Carson,Nature Med.3(2):148-149, 1997.
Kirman and Nielsen,Am. J. Gastroenterol.91(9):1789-1794, 1996.
Kirman et al.,Inflamm. Res.47(7):285-289, 1998.
Kivisakk et al.,Clin. Exp. Immunol.111(1):193-197, 1998.
Li et al.,Transplantation66(2):265-268, 1998.
Liu et al.,J. Immunol.164(7):3608-3615, 2000.
McInnes and Liew,Immunol. Today, 19(2):75-79, 1998.
McInnes et al.,Nature Med.3(2):189-195, 1997.
McInnes et al.,Nature Med.2(2):175-182, 1996.
Park et al.,Yonsei Med.J. 40(4):343-348, 1999.
Pashenkov et al., Scand.J. Immunol.50(3):302-308, 1999.

Affiliated with

Also associated with

Rating

Antagonists of interleukin-15 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antagonists of interleukin-15, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of interleukin-15 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3842731